ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $29,000 | -92.1% | 17,197 | -91.0% | 0.00% | -94.1% |
Q3 2015 | $365,000 | +189.7% | 191,236 | +606.0% | 0.02% | +240.0% |
Q2 2015 | $126,000 | -75.2% | 27,087 | -81.5% | 0.01% | -70.6% |
Q4 2014 | $509,000 | +569.7% | 146,694 | +708.9% | 0.02% | +750.0% |
Q3 2014 | $76,000 | -83.9% | 18,134 | -77.5% | 0.00% | -84.6% |
Q2 2014 | $471,000 | +153.2% | 80,435 | +172.2% | 0.01% | +160.0% |
Q1 2014 | $186,000 | -48.3% | 29,551 | -52.0% | 0.01% | -54.5% |
Q4 2013 | $360,000 | -49.7% | 61,602 | -54.6% | 0.01% | -47.6% |
Q3 2013 | $716,000 | +181.9% | 135,791 | +312.2% | 0.02% | +162.5% |
Q2 2013 | $254,000 | – | 32,939 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |